# Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])

> **NCT00431808** · PHASE1 · UNKNOWN · sponsor: **African Malaria Network Trust** · enrollment: 40 (estimated)

## Conditions studied

- Malaria

## Interventions

- **BIOLOGICAL:** Malaria vaccine AMA1 (PfAMA-1-FVO[25-545]
- **BIOLOGICAL:** AMA1

## Key facts

- **NCT ID:** NCT00431808
- **Lead sponsor:** African Malaria Network Trust
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-05
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2008-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00431808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00431808, "Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00431808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*